Cargando…
Resolution of Sinus Tachycardia Secondary to Hyperthyroidism With Ivabradine
Currently, ivabradine is not approved for the treatment of sinus tachycardia secondary to hyperthyroidism. We aimed to increase the recognition of ivabradine as an effective alternative to, or combination with, beta-blockers in controlling sinus tachycardia secondary to hyperthyroidism. Elevated thy...
Autores principales: | Medina, Yelizaveta, Khan, Asif, Spagnola, Jonathon, Lafferty, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332879/ https://www.ncbi.nlm.nih.gov/pubmed/37434775 http://dx.doi.org/10.14740/jocmr4940 |
Ejemplares similares
-
Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine
por: Sağ, Saim, et al.
Publicado: (2016) -
Inappropriate sinus tachycardia-induced cardiomyopathy with severe functional mitral regurgitation and successful treatment with ivabradine
por: Inamori, Taiji, et al.
Publicado: (2021) -
Ivabradine monotherapy in congenital junctional ectopic tachycardia
por: Devaprasath, Sivalingam, et al.
Publicado: (2022) -
Ivabradine for inappropriate sinus tachycardia-induced symptomatic Mobitz type I atrio-ventricular block: a case summary
por: Korolewicz, James, et al.
Publicado: (2023) -
Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine
por: Karmegaraj, Balaganesh, et al.
Publicado: (2021)